{"id":34657,"date":"2018-05-29T09:00:00","date_gmt":"2018-05-29T07:00:00","guid":{"rendered":"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/"},"modified":"2018-05-29T09:00:00","modified_gmt":"2018-05-29T07:00:00","slug":"ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer","status":"publish","type":"press_release","link":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/","title":{"rendered":"Ipsen et le MD Anderson concluent un accord de partenariat pour le d\u00e9veloppement, du laboratoire au chevet du patient, d\u2019un m\u00e9dicament contre le cancer"},"content":{"rendered":"<\/p>\n<p>Ipsen (Euronext : IPN ; ADR : IPSEY), groupe biopharmaceutique d\u2019envergure internationale, et le MD Anderson Cancer Center de l\u2019Universit\u00e9 du Texas annoncent aujourd\u2019hui la conclusion d\u2019un accord mondial de licence et de d\u00e9veloppement pour un candidat-m\u00e9dicament en oncologie en phase pr\u00e9clinique, d\u00e9couvert par les chercheurs de l\u2019Institute for Applied Cancer Science (IACS) du MD Anderson.<br \/>Dans le cadre de cette collaboration, le MD Anderson va faire progresser le candidat-m\u00e9dicament jusqu\u2019en phase clinique, tandis qu\u2019Ipsen sera en charge de poursuivre son d\u00e9veloppement et de le commercialiser \u00e0 l\u2019\u00e9chelle mondiale.<br \/><b>Le Docteur Alexandre Lebeaut, Vice-Pr\u00e9sident Ex\u00e9cutif, Recherche &amp; D\u00e9veloppement et Chief Scientific Officer Ipsen<\/b>, a d\u00e9clar\u00e9<em>\u00a0: \u00ab\u00a0Nous nous r\u00e9jouissons de ce partenariat avec\u00a0<\/em><em>l\u2019Institute for Applied Cancer Science (IACS) du MD Anderson<\/em><em>\u00a0Cancer Center, dont la r\u00e9putation en termes d\u2019excellence scientifique et de soins cliniques en oncologie est largement reconnue. Gr\u00e2ce \u00e0 cette collaboration, nous esp\u00e9rons pouvoir \u00e9tendre nos capacit\u00e9s \u00e0 proposer le plus t\u00f4t et le plus rapidement possible des m\u00e9dicaments innovants aux patients qui en ont besoin, et ainsi faire avancer la prise en charge des patients en oncologie.\u00a0\u00bb<\/em><br \/>Le MD Anderson et Ipsen travailleront \u00e9galement ensemble pour mener de nouvelles \u00e9tudes pr\u00e9-cliniques afin d\u2019\u00e9valuer les potentialit\u00e9s du m\u00e9canisme d\u2019action du candidat-m\u00e9dicament et son int\u00e9r\u00eat dans de nouvelles indications. Les termes financiers de l\u2019accord, incluant des redevances li\u00e9es au d\u00e9veloppement et aux ventes, et des paiements d\u2019\u00e9tape,n\u2019ont pas \u00e9t\u00e9 communiqu\u00e9s.<br \/><b>Le Docteur Stephen Hahn, Chief Medical Executive au MD Anderson,<\/b>\u00a0a ajout\u00e9 : \u00ab\u00a0<em>Nous sommes convaincus que ce partenariat a le potentiel de mettre \u00e0 la disposition de nos patients une nouvelle option th\u00e9rapeutique. L\u2019objectif premier de ce partenariat, qui est d\u2019acc\u00e9l\u00e9rer le d\u00e9veloppement de traitements efficaces, est au c\u0153ur de notre mission visant \u00e0 \u00e9radiquer le cancer et \u00e0 proposer les meilleurs soins possibles aux personnes qui en ont le plus besoin.\u00bb<\/em><\/p>\n<p> <\/p>\n<p>Sources :<\/p>\n<p><\/p>\n<p><img src='https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png' \/><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[3562],"tags":[],"class_list":["post-34657","press_release","type-press_release","status-publish","hentry","category-partnering-pressrelease-fr","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ipsen et le MD Anderson concluent un accord de partenariat pour le d\u00e9veloppement, du laboratoire au chevet du patient, d\u2019un m\u00e9dicament contre le cancer - Global<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen et le MD Anderson concluent un accord de partenariat pour le d\u00e9veloppement, du laboratoire au chevet du patient, d\u2019un m\u00e9dicament contre le cancer - Global\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/\",\"url\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/\",\"name\":\"Ipsen et le MD Anderson concluent un accord de partenariat pour le d\u00e9veloppement, du laboratoire au chevet du patient, d\u2019un m\u00e9dicament contre le cancer - Global\",\"isPartOf\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"datePublished\":\"2018-05-29T07:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/#primaryimage\",\"url\":\"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"contentUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ipsen et le MD Anderson concluent un accord de partenariat pour le d\u00e9veloppement, du laboratoire au chevet du patient, d\u2019un m\u00e9dicament contre le cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#website\",\"url\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/06\/13064320\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/06\/13064320\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen et le MD Anderson concluent un accord de partenariat pour le d\u00e9veloppement, du laboratoire au chevet du patient, d\u2019un m\u00e9dicament contre le cancer - Global","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Ipsen et le MD Anderson concluent un accord de partenariat pour le d\u00e9veloppement, du laboratoire au chevet du patient, d\u2019un m\u00e9dicament contre le cancer - Global","og_url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/","og_site_name":"Global","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@ipsengroup","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/","url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/","name":"Ipsen et le MD Anderson concluent un accord de partenariat pour le d\u00e9veloppement, du laboratoire au chevet du patient, d\u2019un m\u00e9dicament contre le cancer - Global","isPartOf":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/#primaryimage"},"image":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png","datePublished":"2018-05-29T07:00:00+00:00","breadcrumb":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/#primaryimage","url":"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png","contentUrl":"https:\/\/ml-eu.globenewswire.com\/media\/NGM4MzIxNTgtZDYyNy00Y2I0LWJiMmEtMDNlMDZmNzQ1MWQ5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png"},{"@type":"BreadcrumbList","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/communique-de-presse\/ipsen-et-le-md-anderson-concluent-un-accord-de-partenariat-pour-le-developpement-du-laboratoire-au-chevet-du-patient-dun-medicament-contre-le-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/"},{"@type":"ListItem","position":2,"name":"Ipsen et le MD Anderson concluent un accord de partenariat pour le d\u00e9veloppement, du laboratoire au chevet du patient, d\u2019un m\u00e9dicament contre le cancer"}]},{"@type":"WebSite","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#website","url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#organization","name":"IPSEN","url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/06\/13064320\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/06\/13064320\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]}]}},"_links":{"self":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/press_release\/34657","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":0,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/press_release\/34657\/revisions"}],"wp:attachment":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/media?parent=34657"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/categories?post=34657"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/tags?post=34657"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}